First new PBC treatment in 20 years approved!
The Canadian PBC Society is excited to share that a new treatment option for PBC is on it’s way, thanks to the recent Canadian approval of Ocaliva , otherwise known
Future hope for those who don’t qualify for transplant
More exciting news in Liver Research. Engineered liver tissue could help millions of people who suffer from chronic liver disease but don’t qualify for a liver transplant. – Read More
"Liver Dialysis" Trial Begins in the UK/EU
“Liver dialysis” trial begins in the UK/EU with 24 patients at 7 sites – adding 100 EU patients in 2018.The aim is to remove toxins that accumulate in liver failure
Another PBC Drug going into Phase 2 Trial
“Genkyotex Initiates Patient Enrollment into Phase 2 Trial of GKT831 in Primary Biliary Cholangitis” – Read More
New PBC Drug First Patients enrolled in Phase 2 Trial
“GENFIT: First Patient enrolled in a Phase 2 Trial recruiting Adults with Primary Biliary Cholangitis (PBC), a Rare Liver Disease ” – Read More
New Canadian PBC Patient Registry
In 2016, we designated the proceeds of the Canadian PBC Society’s signature fundraising event, A Day at the Races, to support PBC education, awareness and research at the Toronto Centre
New European Guidelines for PBC Diagnosis and Treatment
In March 2017 New European Guidelines for PBC Diagnosis and Treatment were published. We are very excited that these guidelines include ensuring that patients have access to PBC Patient Support